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Abstract The catalytic activity of the C subunit of serine/
threonine phosphatase 2A is regulated by the association with A
(PR65) and B subunits. It has been reported that the alpha4
protein, a yeast homolog of the Tap42 protein, binds the C
subunit of serine/threonine phosphatase 2A and protein phos-
phatase 2A-related protein phosphatases such as protein
phosphatase 4 and protein phosphatase 6. In the present study,
we showed that alpha4 binds these three phosphatases and the
association of alpha4 reduces the activities of these phosphatases
in vitro. In contrast, PR65 binds to the C subunit of serine/
threonine phosphatase 2A but not to protein phosphatase 4 and
protein phosphatase 6. These results suggest that the alpha4
protein is a common regulator of the C subunit of serine/
threonine phosphatase 2A and protein phosphatase 2A-related
protein phosphatases.
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1. Introduction
Serine/threonine protein phosphatases have important roles
in signal transduction pathways by removing phosphate from
various proteins. These protein phosphatases are classi¢ed
into two classes, as type 1 and type 2 phosphatases [1]. The
type 2 phosphatases is a family of proteins including protein
phosphatase 2 (PP2)A, PP2B and PP2C. Recently, many nov-
el serine/threonine protein phosphatases such as protein phos-
phatase 4 (PP4) and protein phosphatase 6 (PP6) have been
cloned [2].
In mammalian tissues, PP2A exists as a heterotrimer con-
sisting of A (PR65), B (BP, BQ, PR130 or PR72) and C (PP2A-
C) subunits. PP2A-C is a catalytic subunit having a molecule
mass of 36 kDa and two isoforms, K and L, have been iden-
ti¢ed [1]. PP2A-C usually forms a dimer with PR65 and the B
subunit forms a heterotrimer of ABC through the association
with PR65 [1,3,4]. The substrate speci¢city and subcellular
localization of PP2A-C are in£uenced by the interaction of
the regulatory subunits such as PR65 and the B subunit
[1^8]. In mammalians, PP4, or PPX, and PP6 have been iden-
ti¢ed as PP2A-related protein phosphatases [2,9,10]. The over-
all sequence of PP4 and PP6 is closely related to that of
PP2A-C with 66% and 59% identity at the protein level, re-
spectively [9,10]. PP4 is located at the centrosome in the nu-
cleus and little is found in the cytoplasm [2,11]. PP6 is a func-
tional homolog of the budding yeast Sit4. Sit4 is required for
the G1 to S transition of the cell cycle [12]. This implies the
function of PP6 in the cell cycle regulation [10].
The PP2A-related protein phosphatases such as Sit4, Pph21
and Pph22 in yeast are associated with the Tap42 protein
[13,14]. The association of Tap42 with the yeast PP2A-related
protein phosphatases is sensitive to an immunosuppressant
rapamycin [14]. The alpha4 protein was identi¢ed as a
52 kDa phosphoprotein associated with Ig receptor-associated
MB-1 protein in B lymphocytes [15,16]. Alpha4 is a homolog
of the yeast Tap42 protein. Recently, it has been reported that
alpha4 is associated with PP2A-C and type 2A-related protein
phosphatases (PP4 and PP6) in mammalian cells [17^20].
Namely, alpha4 associates with PP2A-C in a rapamycin sen-
sitive manner in COS7 and Jurkat cells and in the immuno-
suppressant-independent way in other cell types such as hu-
man embryonic kidney 293 (HEK293) cells [17^20]. It has
been shown that the association of alpha4 with PP2A-C in-
hibits the catalytic activity in vitro [20]. However, the e¡ects
of the association of alpha4 on the catalytic activity of type
2A-related protein phosphatases have not been elucidated.
Thus, in the present study, we examined the e¡ects of the
association of alpha4 on PP2As (PP4 and PP6) in vitro, using
a p-nitrophenyl phosphate (pNPP) assay.
2. Materials and methods
2.1. Reagents and antibodies
Protein G Sepharose was purchased from Pharmacia Biotech. Ra-
pamycin was purchased from Calbiochem. p-Nitrophenyl phosphoric
acid disodium salt was obtained from Nacalai Tesque. Dulbecco’s
modi¢ed Eagle’s minimal essential medium (DMEM) was from Life
Technologies. Anti-FLAG monoclonal M2 antibody was obtained
from Eastman Kodak. Anti-myc monoclonal antibody was produced
using MYC 1-9E10.2 hybridoma cells (ATCC). Anti-HA monoclonal
antibody (12CA5) was from Boehringer-Mannheim.
2.2. Plasmids and cDNA
pME18S HA vector (HA vector) was gifted from Dr Masa-aki
Muramatsu (Helix Research Institute, Chiba, Japan). pCMV FLAG
vector (FLAG vector) was gifted from Dr Joseph Avruch (Diabetes
Unit, Massachusetts General Hospital, Harvard Medical School).
pcDNA3.1 (-)/Myc-His vector (MYC vector) was purchased from
Invitrogen. Rat PP2A-C L isoform cDNA was gifted from Dr Ta-
kayoshi Kuno (Department of Pharmacology, Kobe University). The
mouse and human EST cDNA clones were obtained from the UK
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HGMP Resource Center. Mouse PR65 and human PP4 were cloned
by PCR using the EST clones AA764624 and AA405553 as templates,
respectively. Human PP6 was cloned from a human skeletal muscle
Quick-Clone cDNA library (Clonetech), using PCR. Sequence analy-
sis of PCR clones was performed on an Applied Biosystem 377 DNA
sequencer. Alpha4 cDNA was obtained as described previously [16]
and inserted into the pcDNA 3.1 (-)/Myc-His vector with the carbox-
yl-terminal myc epitope (Alpha4-MYC). DNA fragments of alpha4
encompassing 1^909 bp, 1^738 bp and 1^591 bp were ampli¢ed by
PCR, using cDNA of wild-type alpha4 as a template, and were in-
serted into the pcDNA3.1 (-)/Myc-His vector to generate deletion
mutants of amino acid 1^303 (Alpha4 mut 303-MYC), amino acid
1^246 (Alpha4 mut 246-MYC) and amino acid 1^197 (Alpha4 mut
197-MYC), respectively. cDNA encoding PR65 was introduced into
the pME18S HA vector with the amino-terminal HA epitope (HA-
PR65). cDNAs encoding PP2A-C, PP4 and PP6 were ligated into the
pCMV FLAG vector with the amino-terminal FLAG epitope
(FLAG-PP2A, FLAG-PP4 and FLAG-PP6), respectively.
2.3. Cell culture and cDNA transfection
HEK293 cells were maintained and cultured in DMEM with 10%
fetal calf serum. Transfection of plasmids in mammalian cells was
carried out by the lipofection method using LipofectAMINE (Life
Technologies). Cells were harvested 36^48 h after transfection.
2.4. Immunoprecipitation and immunoblot
Cells were lysed in ice-cold bu¡er A (50 mM Tris-HCl, pH 8.0, 1%
Nonidet P-40, 120 mM NaCl, 20 mM NaF, 1 mM EDTA, 6 mM
EGTA, 20 mM L-glycerophosphate, 1 mM dithiothreitol, 50 WM
p-amidinophenyl methanesulfonyl £uoride, 2 Wg/ml aprotinin) and
the extracts were centrifuged at 10 000Ug for 20 min at 4‡C. Aliquots
of the supernatant were subjected to immunoprecipitation with anti-
bodies bound on protein G Sepharose beads at 4‡C. The beads were
washed twice with ice-cold bu¡er B (50 mM HEPES, pH 7.4, 0.1%
Triton X-100, 500 mM NaCl). The bound proteins were eluted di-
rectly into SDS sample bu¡er, subjected to SDS-PAGE and trans-
ferred to a PVDF membrane. Immunoblotting was performed using
the ABC peroxidase method (Vectastain).
2.5. pNPP assay
HEK293 cells, transfected with various plasmids as indicated, were
lysed in ice-cold bu¡er C (50 mM Tris-HCl, pH 8.0, 1% Nonidet P-40,
120 mM NaCl, 1 mM EDTA, 6 mM EGTA, 1 mM dithiothreitol,
50 WM p-amidinophenyl methanesulfonyl £uoride, 2 Wg/ml aprotinin).
Transiently expressed FLAG-PP2A-C, FLAG-PP4 and FLAG-PP6
were immunoprecipitated from the cell lysates with anti-FLAG anti-
body bound on protein G Sepharose beads at 4‡C. The complexes of
HA-PR65/FLAG-PP2A-C, myc-alpha4/FLAG-PP2A-C, myc-alpha4/
FLAG-PP4 and myc-alpha4/FLAG-PP6 were precipitated with either
the anti-HA or anti-myc antibodies bound on protein G Sepharose
beads. Beads were washed twice with ice-cold bu¡er B. Beads were
incubated with 1 ml of the reaction mixture, which contains 40 mM
Tris-HCl, pH 8.0, 20 mM KCl, 30 mM MgCl2, 2 mM dithiothreitol,
1 mg/ml bovine serum albumin and 5 mM pNPP, for 20 min at 30‡C.
The reaction was terminated by centrifugation at 10 000Ug for 30 s at
room temperature and the change in absorbance at 400 nm of the
supernatant was measured [21]. The expression of alpha4, PR65,
PP2A-C, PP4 and PP6 were con¢rmed by immunoblotting after im-
munoprecipitation from the aliquots of the cell lysates as described
above.
3. Results
3.1. Association of PR65 with PP2A-C but not with type
2A-related serine/threonine protein phosphatases
We cloned mouse PR65 (accession number AB021743) that
is almost identical to human PR65K (99% identity at the pro-
tein level). Using this mouse PR65, the association of the
regulatory subunit with PP4 and PP6 was examined in the
transfected cells. FLAG-PP2A-C, FLAG-PP4 and FLAG-
PP6 were transiently co-expressed with HA-PR65 in
HEK293 cells. FLAG-PP2A-C was co-immunoprecipitated
with HA-PR65 using anti-HA antibody (Fig. 1A, lane 4 and
Fig. 1B, lane 4), whereas FLAG-PP4 and FLAG-PP6 were
not co-immunoprecipitated with HA-PR65 using anti-HA
antibody (Fig. 1A lane 6 and Fig. 1B, lane 6).
3.2. Association of alpha4 with PP4 and PP6
The association of alpha4 with PP4 and PP6 was examined.
FLAG-PP4 and FLAG-PP6 were co-expressed with myc-al-
pha4 in HEK293 cells. FLAG-PP4 and FLAG-PP6 were co-
immunoprecipitated with myc-alpha4 using anti-myc antibody
(Fig. 2A, upper panel, lane 4 and Fig. 2B, upper panel, lane 4)
and myc-alpha4 was co-immunoprecipitated with FLAG-PP4
and FLAG-PP6 using anti-FLAG M2 antibody (Fig. 2A, low-
er panel, lane 4 and Fig. 2B, lower panel, lane 4). Then we
examined the e¡ects of rapamycin on the association of al-
pha4 with PP4 and PP6. The dissociation of alpha4 from PP4
and PP6 was not observed in rapamycin-treated cells (Fig. 2A,
lane 5 and Fig. 2B, lane 5).
Next, to examine the region of alpha4 required for the
association of PP2A-C and type 2A-related protein phospha-
tases, three deletion mutants of alpha4 were constructed.
FLAG-PP2A-C, FLAG-PP4 and FLAG-PP6 were co-ex-
pressed with wild-type or mutants of myc-alpha4 in
HEK293 cells. FLAG-PP2A-C, FLAG-PP4 and FLAG-PP6
were co-immunoprecipitated with wild-type myc-alpha4, Al-
pha4 mut 303-MYC and Alpha4 mut 246-MYC using anti-
myc antibody (Fig. 3, left panels, lanes 3^5). In addition, wild-
type myc-alpha4, Alpha4 mut 303-MYC and Alpha4 mut 246-
MYC were co-immunoprecipitated with FLAG-PP2A-C,
FLAG-PP4 and FLAG-PP6 using anti-FLAG M2 antibody
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Fig. 1. Association of PR65 with PP2A-C. HEK293 cells cultured in
60 mm dishes were transfected with 500 ng FLAG-PP4 (A: lanes 5
and 6) and 100 ng FLAG-PP6 (B: lanes 5 and 6). In addition, cells
were transfected with the same plasmid DNAs in A and B as fol-
lows: lane 1, mock transfection; lane 2, 100 ng FLAG vector; lanes
3 and 5, 2 Wg HA vector; lanes 2, 4 and 6, 2 Wg HA-PR65; lanes 3
and 4, 100 ng FLAG-PP2A. After extraction, immunoprecipitates
with either anti-HA antibody (A and B: upper panels) or anti-
FLAG M2 antibody (A and B: lower panel) were subjected to 10%
SDS-PAGE and an immunoblot was carried out using a mixture of
anti-HA and anti-FLAG M2 antibodies (A and B: upper panels) or
anti-FLAG M2 antibody (A and B: lower panels) as the ¢rst anti-
bodies.
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(Fig. 3, right panels, lanes 3^5). However, FLAG-PP2A-C,
FLAG-PP4 and FLAG-PP6 were not co-immunoprecipitated
with Alpha4 mut 197-MYC (Fig. 3, left panels, lane 6). Con-
sistent with this, Alpha4 mut 197-MYC was not co-immuno-
precipitated with FLAG-PP2A-C, FLAG-PP4 or FLAG-PP6
(Fig. 3, right panels, lane 6).
3.3. Inhibition of the catalytic activity of PP2A-C and type
2A-related protein phosphatases by alpha4
We examined the e¡ects of the association of alpha4 on the
phosphatase activity of PP2A-C, PP4 and PP6 using a pNPP
assay. FLAG-PP2A-C was immunoprecipitated with anti-
FLAG M2 antibody bound on protein G Sepharose beads
and FLAG-PP2A-C in complex with HA-PR65 were co-im-
munoprecipitated with anti-HA antibody bound on protein G
Sepharose. Both forms of PP2A-C dephosphorylated pNPP
(Fig. 4A, lower panel, lanes 4 and 5). In consistent with our
previous report [18], FLAG-PP2A-C in complex with myc-
alpha4, co-precipitated with anti-myc antibody bound on pro-
tein G Sepharose, exhibited a diminished phosphatase activity
toward pNPP (Fig. 4A, lower panel, lane 6). Immunoblot
analysis revealed that the amount of PP2A-C in the complex
form with alpha4 (Fig. 4A, upper panel, lane 6) was higher
than either that of the free form of PP2A-C (Fig. 4A, upper
panel, lane 4) or that in complex form with HA-PR65 (Fig.
4A, upper panel, lane 5). FLAG-PP4 and FLAG-PP6, immu-
noprecipitated with anti-FLAG antibody bound on protein G
Sepharose, dephosphorylated pNPP (Fig. 4B,C, lower panel,
lane 3). The catalytic activity of PP6 is weaker than that of
PP2A-C and PP4 (Fig. 4A, lower panel, lane 4 and Fig. 4B,C,
lower panel, lane 3). FLAG-PP4 and FLAG-PP6 in complex
with myc-alpha4 also showed a signi¢cant diminished phos-
phatase activity toward pNPP (Fig. 4B,C, lanes 4). The
amounts of FLAG-PP4 and FLAG-PP6 in complex with al-
pha4 (Fig. 4B,C, upper panel, lane 4) were almost equal to
that of the free form of FLAG-PP4 and FLAG-PP6 (Fig.
4B,C, upper panel, lane 3).
4. Discussion
In the present study, we reported that PR65 binds to PP2A-
C but not to PP4 or PP6, whereas alpha4 binds to PP2A-C
and type 2A-related protein phosphatases. It has been shown
that PR65 binds to PP2A-C but not to PP4 [11] and that
alpha4 binds to PP2A-C and type 2A-related protein phos-
phatases [19]. Taken together, these results suggest that PR65
is a regulatory subunit speci¢c to PP2A-C and that alpha4 is a
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Fig. 3. Association of PP2A-C, PP4 and PP6 with wild-type and deletion mutants of alpha4. HEK293 cells in 60 mm dishes were transfected
with 100 ng FLAG-PP2A (upper panels, lanes 2^6), 500 ng FLAG-PP4 (middle panels, lanes 2^6), 100 ng FLAG-PP6 (lower panels, lane 2^6)
and the other plasmid DNAs (all panels: lane 1, mock transfection; lane 2, 2 Wg MYC vector; lane 3, 2 Wg Alpha4-MYC; lane 4, 2 Wg Alpha4
mut 303-MYC; lane 5, 2 Wg Alpha4 mut 246-MYC; lane 6, 4 Wg Alpha4 mut 197-MYC). After extraction, immunoprecipitates with either
anti-myc antibody (left panels) or anti-FLAG M2 antibody (right panels) were subjected to 12% SDS-PAGE and animmunoblot was carried
out using a mixture of anti-alpha4 and anti-PP2A-C polyclonal antibodies (upper panels) or a mixture of anti-myc and anti-FLAG M2 mono-
clonal antibodies (middle and lower panels). Asterisks indicate the positions of the wild-type and three deletion mutants of alpha4.
Fig. 2. Association of alpha4 with PP4 and PP6. HEK293 cells cul-
tured in 60 mm dishes were transfected with 500 ng FLAG vector
(A: lane 2), 500 ng FLAG-PP4 (A: lanes 3^5), 100 ng FLAG vec-
tor (B: lane 2) and 100 ng FLAG-PP6 (B: lanes 3^5). In addition,
cells were transfected with the same plasmid DNAs in A and B as
follows: lane 1, mock transfection; lane 3, 2 Wg MYC vector; lane
2, 4 and 5, 2 Wg Alpha4-MYC. In lane 5 (A and B), cells were
treated with 100 nM rapamycin for 30 min at 37‡C. After extrac-
tion, immunoprecipitates with either anti-myc antibody (A and B:
upper panels) or anti-FLAG M2 antibody (A and B: lower panels)
were subjected to 10% SDS-PAGE and an immunoblot was carried
out using a mixture of anti-myc and anti-FLAG M2 antibodies (A
and B: upper and lower panels) as the ¢rst antibodies.
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common regulator among PP2A-C and type 2A-related pro-
tein phosphatases.
It has been reported that alpha4 binds directly to PP2A-C
but not together with PR65 [17]. We also found that PP2A-C
is associated with either alpha4 or PR65 and that PP2A-C,
alpha4 and PR65 do not form a ternary complex (data not
shown). This also indicates that alpha4 does not form a com-
plex with PP2A-C through the association with PR65.
We examined the region of alpha4 which is important for
the binding to PP2A-C, PP4 and PP6. All of the three phos-
phatases bound the alpha4 fragment of the amino-terminal
246 amino acids but not to the alpha4 fragment of the ami-
no-terminal 197 amino acids. Our previous report has shown
that the region encompassing 109 amino acids in the middle
portion of alpha4 (94^202 amino acids) was necessary and
su⁄cient for the binding to PP2A-C [18]. These results suggest
that PP2A-C, PP4 and PP6 bind to the same region of alpha4
and the region including amino acid 198^202 is critical for the
binding of PP2A-C and type 2A-related protein phosphatases.
Finally, It was examined how the association of alpha4 with
type 2A-related protein phosphatases a¡ects the catalytic ac-
tivity. We have reported that alpha4 inhibits the phosphatase
activity of PP2A-C toward 32P-phosphorylated eIF-4E bind-
ing protein 1 (4E-BP1), a component of the translation initia-
tion complex [20]. It has been reported that 4E-BP1 is a
downstream e¡ector of growth factor receptors [22] and the
mammalian target of rapamycin (mTOR) [23,24] and mTOR
exhibits a kinase activity toward 4E-BP1 in vitro [25]. How-
ever, the phosphatase activity of PP6 was hardly detected
toward 32P-phosphorylated 4E-BP1. Thus, we employed
pNPP as a substrate to investigate the phosphatase activity
of PP2A-C, PP4 and PP6 in this study. The association with
alpha4 inhibited the catalytic activity of PP2A-C, PP4 and
PP6. (Fig. 4). These results suggest that alpha4 may be a
negative regulator of type 2A-related serine/threonine phos-
phatases. However, the physiological substrates of PP4 and
PP6 have not yet been identi¢ed. It has been demonstrated
that the modulation of PP2A-C activity by the association
with PR65 is dependent on the size of the substrate [26].
pNPP is not a protein substrate but a small organic molecule.
Although we show here that alpha4 is the common negative
regulatory subunit of PP2A-C, PP4 and PP6 in vitro, further
investigations will be required to ¢nd physiologically relevant
protein substrates and how alpha4 regulates the catalytic ac-
tivity of type 2A-related protein phosphatases.
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